Reoxygenation during radiotherapy in intermediate-risk prostate cancer
- PMID: 30935573
- DOI: 10.1016/j.radonc.2018.12.022
Reoxygenation during radiotherapy in intermediate-risk prostate cancer
Abstract
Hypoxia is a major risk factor of prostate cancer radioresistance. We evaluated hypoxia non-invasively, using 18F-Misonidazole PET/CT prior to radiotherapy and after a dose of 20 Gy in intermediate-risk prostate cancer patients. Decreased hypoxic volumes were observed in all patients, suggesting that radiotherapy induces early prostate tumor reoxygenation.
Keywords: Dose painting radiotherapy; FAZA; IMRT; Misonidazole; Radioresistance.
Copyright © 2019 Elsevier B.V. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical